Sui T, Zhang J, Du S, Su C, Que J, Cao X
Neural Regen Res. 2014; 9(8):821-7.
PMID: 25206895
PMC: 4146259.
DOI: 10.4103/1673-5374.131598.
BHymer C, Connor T, Stinson D, Pretty J
J Chromatogr Sci. 2014; 53(4):619-24.
PMID: 25129062
PMC: 4556226.
DOI: 10.1093/chromsci/bmu095.
Jeong C, Jeon H, Kwak C, Jeong H, Lee S
Cancer Res Treat. 2009; 37(1):44-7.
PMID: 19956509
PMC: 2785421.
DOI: 10.4143/crt.2005.37.1.44.
Bono A
Cancer Chemother Pharmacol. 1994; 35 Suppl:S101-9.
PMID: 7994780
DOI: 10.1007/BF00686931.
Narisawa T, Sato M, Tani M, Takahashi T
J Cancer Res Clin Oncol. 1980; 97(3):223-32.
PMID: 6777388
DOI: 10.1007/BF00405773.
Treatment of superficial bladder cancer.
Morales A
Can Med Assoc J. 1980; 122(10):1133-8.
PMID: 6770987
PMC: 1801981.
Intravesical adriamycin chemotherapy in bladder cancer.
Matsumura Y, Ozaki Y, Ohmori H
Cancer Chemother Pharmacol. 1983; 11 Suppl:S69-73.
PMID: 6640838
DOI: 10.1007/BF00256723.
Bladder instillation of adriamycin in the treatment of bladder cancer.
Huang C, Chiang C
Cancer Chemother Pharmacol. 1983; 11 Suppl:S91-3.
PMID: 6605814
DOI: 10.1007/BF00256728.
Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.
Niijima T, Koiso K, Akaza H
Cancer Chemother Pharmacol. 1983; 11 Suppl:S79-82.
PMID: 6416701
DOI: 10.1007/BF00256725.
Dermatitis due to mitomycin bladder instillations.
Neild V, Sanderson K, RIDDLE P
J R Soc Med. 1984; 77(7):610-1.
PMID: 6235369
PMC: 1439963.
DOI: 10.1177/014107688407700716.
Intravesical chemotherapy in the United States. An overview.
Spaulding J
Cancer Chemother Pharmacol. 1983; 11 Suppl:S5-8.
PMID: 6196136
DOI: 10.1007/BF00256708.
Methodologies for quantifying the results of intravesical chemotherapy of superficial tumors of the bladder.
Jauhiainen K, ALFTHAN O
Med Oncol Tumor Pharmacother. 1985; 2(4):249-54.
PMID: 3937002
DOI: 10.1007/BF02934910.
Intravesical chemotherapy.
Obama T, Matsumura Y, Ohmori H
Cancer Chemother Pharmacol. 1987; 20 Suppl:S60-2.
PMID: 3664946
DOI: 10.1007/BF00262488.
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
Tolley D, Hargreave T, Smith P, Williams J, Grigor K, Parmar M
Br Med J (Clin Res Ed). 1988; 296(6639):1759-61.
PMID: 3136828
PMC: 2546235.
DOI: 10.1136/bmj.296.6639.1759.
Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group.
Akaza H, ISAKA S, Koiso K, Kotake T, Machida T, Maru A
Cancer Chemother Pharmacol. 1987; 20 Suppl:S91-6.
PMID: 3117403
DOI: 10.1007/BF00262495.
Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C.
ISAKA S, Okano T, Shimazaki J, Igarashi T, Murakami S, Higa T
Cancer Chemother Pharmacol. 1987; 20 Suppl:S77-80.
PMID: 3117401
DOI: 10.1007/BF00262492.
Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
Tsushima T, Matsumura Y, Ozaki Y, Yoshimoto J, Ohmori H
Cancer Chemother Pharmacol. 1987; 20 Suppl:S72-6.
PMID: 3117400
DOI: 10.1007/BF00262491.
Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors.
Fukui I, Sekine H, Kihara K, Yamada T, Kawai T, Washizuka M
Cancer Chemother Pharmacol. 1987; 20 Suppl:S52-5.
PMID: 3117399
DOI: 10.1007/BF00262486.
Size and location of tumors influencing the effect of bladder instillation therapy.
Watanabe H, Nakao M, Nakagawa S, Takada H
Cancer Chemother Pharmacol. 1987; 20 Suppl:S49-51.
PMID: 3117398
DOI: 10.1007/BF00262485.
Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group.
Newling D
Br J Cancer. 1990; 61(4):497-9.
PMID: 2184878
PMC: 1971356.
DOI: 10.1038/bjc.1990.112.